Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rovelli

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
The International Journal of Biological Markers|July 1, 1989
Interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors in patients with solid tumors are not correlatedP Lissoni, V Rizzo, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Interleukin-12 in early or advanced cancer patientsP Lissoni, F Rovelli, S Pittalis, et al.
Circulation|February 1, 1993
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 resultsA P Maggioni, G Zuanetti, M G Franzosi, et al.
Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemiaP Lissoni, M Vaghi, S Pescia, et al.
In Vivo (Athens, Greece)|February 3, 2009
A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviourG Messina, P Lissoni, F Brivio, et al.
Oncology Reports|May 21, 2011
Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasmsP Lissoni, A Ardizzoia, S Barni, et al.
European Heart Journal|December 1, 1986
Indications for surgical treatment in post-infarction anginaL Campolo, A M DeBiase, A Mafrici, et al.
Journal of Biological Regulators and Homeostatic Agents|February 24, 2001
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic diseaseP Lissoni, F Brivio, F Rovelli, et al.
Lancet (London, England)|July 20, 1996
Health services: an Italian marketA del Favero, G Barro, G Vicari, et al.
Tumori|December 31, 1991
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patientsS Spinazzé, S Viviani, P Bidoli, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
The International Journal of Biological Markers|July 1, 1989
Interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors in patients with solid tumors are not correlatedP Lissoni, V Rizzo, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Interleukin-12 in early or advanced cancer patientsP Lissoni, F Rovelli, S Pittalis, et al.
Circulation|February 1, 1993
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 resultsA P Maggioni, G Zuanetti, M G Franzosi, et al.
Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemiaP Lissoni, M Vaghi, S Pescia, et al.
In Vivo (Athens, Greece)|February 3, 2009
A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviourG Messina, P Lissoni, F Brivio, et al.
Oncology Reports|May 21, 2011
Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasmsP Lissoni, A Ardizzoia, S Barni, et al.
European Heart Journal|December 1, 1986
Indications for surgical treatment in post-infarction anginaL Campolo, A M DeBiase, A Mafrici, et al.
Journal of Biological Regulators and Homeostatic Agents|February 24, 2001
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic diseaseP Lissoni, F Brivio, F Rovelli, et al.
Lancet (London, England)|July 20, 1996
Health services: an Italian marketA del Favero, G Barro, G Vicari, et al.
Tumori|December 31, 1991
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patientsS Spinazzé, S Viviani, P Bidoli, et al.
Pageof 18